期刊文献+

磷霉素在治疗肝硬化并发自发性腹膜炎中的协同作用 被引量:2

下载PDF
导出
摘要 对照观察磷霉素在头孢哌酮/舒巴坦治疗肝硬化合并自发性腹膜炎(SBP)中的协同作用。结论:磷霉素可减少联用药物剂量,安全性高,在协同治疗方面有良好优势。
作者 叶英 李家斌
出处 《中国社区医师》 2008年第4期25-25,共1页 Chinese Community Doctors
  • 相关文献

共引文献379

同被引文献19

  • 1徐修礼,胡晓卫,孙怡群,樊新,程晓东.万古霉素和左氧氟沙星对金黄色葡萄球菌的体外联合抗菌活性研究[J].中国药物与临床,2007,7(7):541-542. 被引量:4
  • 2CDC. Staphylococcus aureus resistant to vancomycin-united states[J]. MMWR, 2002,51 (26) :565 - 567. 被引量:1
  • 3Lodise TP, Graves J, Evans A. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vaneomycin[J]. Antimicrob Agents Chemother, 2008,52 ( 9 ) : 3315 - 3320. 被引量:1
  • 4Kumon H, Ono N, Iida M, et al. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm[J].Antimicrob Agents Chemother, 1995 ,39(5):1038-1044. 被引量:1
  • 5Nakazawa H, Kikuchi Y, Honda T,et al. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin[J]. J Infect Chemother ,2003,9(4):304-309. 被引量:1
  • 6Mikuniya T, Kato Y, Kariyama R,et al. Synergistic effect of fosfomycin and fluoroquinolones against "Pseudomonas aeruginosa growing in a biofilm[J]. Acta Med Okayama, 2005,5(59):209-216. 被引量:1
  • 7Zeitlinger M, Marsik C, Steiner I,et al . Immunomodulatory effects of fosfomycin in an endotoxin model in human blood [J]. J Antimicrob Chemother,2007,59(2) :219-223. 被引量:1
  • 8Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, et al. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible staphylococcus aureus[J]. Rev Esp Quimoterap Septiembre,2006,19 (3) : 252--257. 被引量:1
  • 9Lau WY, Teoh-chan CH, Fan ST. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia [J]. J Hyg (Lond),1986, 93(3) : 419-423. 被引量:1
  • 10Leonard SN, Kaatz GW,Rucker LR, et al. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillinresistant Staphylococcus aureus [J]. J Antimicrob Chemother,2008, 62(6) :1305-1310. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部